Search
 

Some Notes on Rite Aid's Purchase of EnvisionRx

The market has reacted favorably to Rite Aide's purchase of EnvisionRX for $2 Billion in cash and stock.

By Jonathan Hipp | Updated on February 11, 2015

On Wednesday, February 11, 2015 Rite Aid agreed to the purchase of top pharmacy benefit manager, Envision Pharmaceutical Services for roughly $2 Billion in cash and stock. Below are some reactions to the transaction:

  • The market has reacted favorably to Rite Aid’s purchase. The company’s stock is up about 10% today (above $8). This is a far cry from when Rite Aid’s stock was trading at $.22 per share.
  • It is amazing that Rite Aid made such a large acquisition primarily from cash.
  • The acquisition is predicted to add about $5 billion dollars to Rite Aid’s sales. The transactions is a strong add to top line growth and accretive to Rite Aid this year.
  • Rite Aid (Rated B2 by Moody’s) is just catching up with CVS and Walgreens that have previously acquired benefits managers but it is a welcome addition.
  • With regard to net lease investment sales, Rite Aid cap rates have dramatically compressed in the last two years and Rite Aid properties with longer term leases are now being offered in the low 6′s.
  • On the negative side, Rite Aid is still developing a small number of new stores per year so there aren’t very many Rite Aids on the market.

Want to continue reading?
Become a Free ALM Digital Reader.

Once you are an ALM digital member, you’ll receive:

  • Unlimited access to GlobeSt and other free ALM publications
  • Access to 15 years of GlobeSt archives
  • Your choice of GlobeSt digital newsletters and over 70 others from popular sister publications
  • 1 free article* every 30 days across the ALM subscription network
  • Exclusive discounts on ALM events and publications

*May exclude premium content
Already have an account?

NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

GlobeSt

Join GlobeSt

Don't miss crucial news and insights you need to make informed commercial real estate decisions. Join GlobeSt.com now!

  • Free unlimited access to GlobeSt.com's trusted and independent team of experts who provide commercial real estate owners, investors, developers, brokers and finance professionals with comprehensive coverage, analysis and best practices necessary to innovate and build business.
  • Exclusive discounts on ALM and GlobeSt events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com.

Already have an account? Sign In Now
Join GlobeSt

Copyright © 2024 ALM Global, LLC. All Rights Reserved.